24th January 2022

$2.8m MRFF boost for vital cancer immunotherapy research

Mater Research will begin trialing a new targeted immunotherapy in 2022 to treat a rare but devastating blood cancer thanks to a $2.8m grant

Latest News

9 June 2021

Immune cells found to attack melanoma

Prof Gabrielle Belz and her team discovered a type of immune cells can halt the rapid development of melanoma
More about Immune cells found to attack melanoma
7 June 2021

3D-printed kidney model proves effective as hands-on education tool

ACCISS has developed a 3D-printed kidney model as a hands-on education tool for A&TSI patients
More about 3D-printed kidney model proves effective as hands-on education tool
6 June 2021

Funding for Translational Manufacturing Institute

Queensland Government announces funding support for the Translational Manufacturing Institute at TRI
More about Funding for Translational Manufacturing Institute
31 May 2021

Vaccine response linked to hormone

TRI-based Prof Di Yu and his team have discovered the metabolic hormone, leptin, can influence the body's response to vaccines.
More about Vaccine response linked to hormone
13 May 2021

AI opening new fields for cancer researchers

Dr Pascal Duijf is using AI to unearth potential new treatments for cancers
More about AI opening new fields for cancer researchers
10 May 2021

UQDI RESEARCHERS FIND NEW WAY TO REDUCE SCARRING

Prof Kiarash Khosrotehrani and his team discover molecule target to reduce scarring.
More about UQDI RESEARCHERS FIND NEW WAY TO REDUCE SCARRING

Pages

Events

21 March 2022 9:30 AM6:00 PM

ASSC Genetics Summit 21 March 2022

The Australian Skin and Skin Cancer Research Centre (ASSC) is hosting the Genetics Summit
More about ASSC Genetics Summit 21 March 2022

Upcoming Events

Sorry, no results found

Please try again with less restrictive search criteria